YSM News and Recognition

AI detects changes that may predict major diseases; finding a potential target for autoimmune conditions; and developing a "Trojan horse" cancer therapy.

News

July 11, 2024
The use of AI to measure immune health could lead to precision medicine tools that assess an individual’s current and future health trajectory, a Yale study finds.

July 11, 2024
A gene mutation that causes human immune defects reveals new biology of antibody responses and may open the door to new autoimmune disease treatments, a Yale-led study has found.

July 15, 2024

Antinuclear antibody-drug conjugates were effective against mouse models of breast cancer and colon cancer, and even improved survival in mouse models of glioma. Efforts are underway to advance this therapy to testing in the clinical trial setting.

July 12, 2024

Research finds that Spanish-speaking patients are less likely to receive a prompt diagnosis of cognitive impairment than English-speaking patients, due to several cultural and environmental factors, as well as systemic problems in health care.

July 11, 2024

A team at Yale has identified a protein that helps the body sense and respond to changes in shear stress.

July 11, 2024

The program, operated by Yale Medicine (YM) and Yale New Haven Health System (YNHHS), is designed to bring health care to people where they live.

Recognition

Aneni Earns a NIDA Career Development Award

Kammarauche Aneni, MBBS, MHS, assistant professor of child psychiatry, has received a National Institute on Drug Abuse (NIDA) Career Development Award. The award will allow Aneni to develop a family-based digital intervention to address early substance misuse among Black adolescents while promoting training in community-engaged research, and developing culturally tailored family-based digital interventions and implementation science methods.

D'Onofrio Will Co-lead NIH Program to Train Early-career Emergency Physicians

Gail D'Onofrio, MD, MS, Albert E. Kent Professor of Emergency Medicine, will serve as one of two program leaders of the newly announced Neuro-EM Scholars K12 Program, which is supported by three institutes of the National Institutes of Health (NIH). The program will support training and mentorship of early-career emergency physicians to conduct high-impact research focused on neurological disorders commonly seen in pre-hospital and emergency department settings.

Miller Co-hosts Annual Roundable

Jennifer Miller, PhD, associate professor of medicine (general medicine), co-hosted the 19th roundtable on "Bioethics, Health Equity and the Role of Pharma" on June 24 in New York City with Ernst & Young, in collaboration with the Yale Program for Biomedical Ethics (of which she is co-director) and Scientific American. The session brought together academics, clinicians, policy makers, patient groups, pharmacies, and the pharma sector to discuss key ethics and trust concerns in medicine and vaccine development and ways to address challenges.

Rho Will Be Child Neurology Section Chief

Jong M. Rho, MD, will be the new section chief of Child Neurology, effective December 1, 2024. Rho comes to Yale from the Division of Pediatric Neurology at Rady Children’s Hospital San Diego and the departments of Neurosciences, Pediatrics, and Pharmacology at the University of California San Diego.

Roberts Is Elected an ASTRO Fellow

Kenneth Roberts, MD, professor of therapeutic radiology, has been elected a Fellow of the American Society for Radiation Oncology (ASTRO). Roberts cares for patients with pediatric malignancies, lymphomas, leukemias, sarcomas, colo-anal cancers, and benign inflammatory conditions. His clinical research interests focus on combined modality therapy in cancer management, late effects of therapy including secondary malignancies, and the use of brachytherapy in both malignant and benign disease.

Saltzman, Springer, and Shenoi Receive WHRY Pilot Awards

W. Mark Saltzman, PhD, Goizueta Foundation Professor of Chemical and Biomedical Engineering, has received a Wendy U. & Thomas C. Naratil Pioneer Award from Women's Health Research at Yale (WHRY), to develop and test long-acting degradable implants designed to treat endometriosis. This approach offers the novel delivery of an FDA-approved drug to treat this common disorder. Sandra Springer, MD, professor of medicine, and Sheela Shenoi, MD, MPH, associate professor of medicine, received a WHRY Pilot Project Program award to explore how a mobile model of health care can improve outcomes when women rejoin the community after incarceration.

Schnakenberg Martin Receives an APA Early Career Achievement Award

Ashley M. Schnakenberg Martin, PhD, assistant professor of psychiatry, has received a Psychologists in Public Service Early Career Achievement Award from the American Psychological Association (APA) Division 18: Psychologists in Public Service.

If you have good news to share, we'd like to hear from you

Nominate someone who you think deserves recognition, including yourself!